全文获取类型
收费全文 | 107558篇 |
免费 | 6121篇 |
国内免费 | 650篇 |
专业分类
耳鼻咽喉 | 1046篇 |
儿科学 | 3503篇 |
妇产科学 | 2460篇 |
基础医学 | 15477篇 |
口腔科学 | 3991篇 |
临床医学 | 9750篇 |
内科学 | 24258篇 |
皮肤病学 | 2721篇 |
神经病学 | 10495篇 |
特种医学 | 2496篇 |
外国民族医学 | 1篇 |
外科学 | 9554篇 |
综合类 | 397篇 |
一般理论 | 50篇 |
预防医学 | 10740篇 |
眼科学 | 1739篇 |
药学 | 7529篇 |
中国医学 | 418篇 |
肿瘤学 | 7704篇 |
出版年
2024年 | 121篇 |
2023年 | 1031篇 |
2022年 | 2219篇 |
2021年 | 3674篇 |
2020年 | 2303篇 |
2019年 | 3091篇 |
2018年 | 3522篇 |
2017年 | 2684篇 |
2016年 | 3116篇 |
2015年 | 3457篇 |
2014年 | 4536篇 |
2013年 | 5918篇 |
2012年 | 8985篇 |
2011年 | 9349篇 |
2010年 | 5087篇 |
2009年 | 4289篇 |
2008年 | 7418篇 |
2007年 | 7422篇 |
2006年 | 6836篇 |
2005年 | 6368篇 |
2004年 | 5712篇 |
2003年 | 5070篇 |
2002年 | 4555篇 |
2001年 | 536篇 |
2000年 | 380篇 |
1999年 | 587篇 |
1998年 | 797篇 |
1997年 | 650篇 |
1996年 | 549篇 |
1995年 | 450篇 |
1994年 | 430篇 |
1993年 | 352篇 |
1992年 | 291篇 |
1991年 | 188篇 |
1990年 | 197篇 |
1989年 | 178篇 |
1988年 | 177篇 |
1987年 | 146篇 |
1986年 | 158篇 |
1985年 | 110篇 |
1984年 | 135篇 |
1983年 | 132篇 |
1982年 | 155篇 |
1981年 | 115篇 |
1980年 | 124篇 |
1979年 | 77篇 |
1978年 | 77篇 |
1977年 | 71篇 |
1976年 | 64篇 |
1974年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
971.
BACKGROUND: Inflammatory processes are a rare cause of peripheral facial palsy. In most cases even massive infection does not lead to a loss of facial nerve function. In the literature, only 8 cases of facial paralysis associated with parotid cyst have been described. PATIENT AND RESULTS: We present a case of facial palsy caused by an inflamed cyst of the parotid gland. The patient was operated on with the diagnosis malignant parotid tumor. The pathological report showed a squamous epithelial cyst, massive lymphocytic infiltration. CONCLUSIONS: As a rule the combination parotid gland lesion and facial palsy is a sign of malignancy, clinicians should be aware that, on rare occasions, facial nerve dysfunction may result from benign parotid gland disease. 相似文献
972.
973.
Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001
下载免费PDF全文
![点击此处可从《Pediatric blood & cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Uma H. Athale Maneka Puligandla Kristen E. Stevenson Barbara Asselin Luis A. Clavell Peter D. Cole Kara M. Kelly Caroline Laverdiere Jean‐Marie Leclerc Bruno Michon Marshall A. Schorin Maria Luisa Sulis Jennifer J. G. Welch Marian H. Harris Donna S. Neuberg Stephen E. Sallan Lewis B. Silverman 《Pediatric blood & cancer》2018,65(10)
974.
Stefania Napolitano Vincenza Caputo Anna Ventriglia Giulia Martini Carminia Maria Della Corte Vincenzo De Falco Stefano Ferretti Erika Martinelli Floriana Morgillo Davide Ciardiello Ferdinando De Vita Michele Orditura Morena Fasano Fortunato Ciardiello Teresa Troiani 《The oncologist》2022,27(8):e633
CoronaVirus disease-2019 has changed the delivery of health care worldwide and the pandemic has challenged oncologists to reorganize cancer care. Recently, progress has been made in the field of precision medicine to provide to patients with cancer the best therapeutic choice for their individual needs. In this context, the Foundation Medicine (FMI)-Liquid@Home project has emerged as a key weapon to deal with the new pandemic situation. FoundationOne Liquid Assay (F1L) is a next-generation sequences-based liquid biopsy service, able to detect 324 molecular alterations and genomic signatures, from May 2020 available at patients’ home (FMI-Liquid@Home). We analyzed time and costs saving for patients with cancer, their caregivers and National Healthcare System (NHS) with FMI-Liquid@Home versus F1L performed at our Department. Different variables have been evaluated. Between May 2020 and August 2021, 218 FMI-Liquid@Home were performed for patients with cancer in Italy. Among these, our Department performed 153 FMI-Liquid@Home with the success rate of 98% (vs. 95% for F1L in the hospital). Time saving for patients and their caregivers was 494.86 and 427.36 hours, respectively, and costs saving was 13 548.70€. Moreover, for working people these savings were 1084.71 hours and 31 239.65€, respectively. In addition, the total gain for the hospital was 163.5 hours and 6785€, whereas for NHS was 1084.71 hours and 51 573.60€, respectively. FMI-Liquid@Home service appears to be useful and convenient allowing time and costs saving for patients, caregivers, and NHS. Born during the COVID-19 pandemic, it could be integrated in oncological daily routine in the future. Therefore, additional studies are needed to better understand the overall gain and how to integrate this service in different countries. 相似文献
975.
976.
977.
978.
Claire Petit Benjamin Lacas Jean-Pierre Pignon Quynh Thu Le Vincent Grégoire Cai Grau Allan Hackshaw Björn Zackrisson Mahesh K B Parmar Ju-Whei Lee Maria Grazia Ghi Giuseppe Sanguineti Stéphane Temam Maurice Cheugoua-Zanetsie Brian O'Sullivan Marshall R Posner Everett E Vokes Juan J Cruz Hernandez L.P. Zhong 《The lancet oncology》2021,22(5):727-736
979.
980.
Roberto Orecchia Umberto Veronesi Patrick Maisonneuve Viviana Enrica Galimberti Roberta Lazzari Paolo Veronesi Barbara Alicja Jereczek-Fossa Federica Cattani Claudia Sangalli Alberto Luini Pietro Caldarella Marco Venturino Daniele Sances Stefano Zurrida Giuseppe Viale Maria Cristina Leonardi Mattia Intra 《The lancet oncology》2021,22(5):597-608